OTCMKTS:CNXR (CNXR) (CNXR) Stock Price, News & Analysis → The last Republican president? (From The Freeport Society) (Ad) Free CNXR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.35▼$0.3550-Day Range N/A52-Week Range$0.35▼$0.35Volume400 shsAverage Volume78,068 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (CNXR) alerts: Email Address Ad The Freeport SocietyThe last Republican president?History shows Donald Trump is poised to go down as the last Republican President for a generation or more. How is this possible, with Biden so unpopular, and Trump running at least neck-in-neck with him in polls?This presentation explains exactly why. About (CNXR) Stock (OTCMKTS:CNXR)Connecture, Inc. provides a Web-based consumer shopping, enrollment and retention platform for health insurance distribution. The Company caters its services to health insurance marketplace operators, such as health plans, brokers and exchange operators. It operates through four segments: Enterprise/Commercial, Enterprise/State, Medicare and Private Exchange. The Enterprise/Commercial segment offers insurance distribution solutions to health plans. The Enterprise/State segment offers the sales automation solutions to state Governments, which allow its customers to offer customized individual and small group exchanges. The Medicare segment offers Web-based Medicare plan comparison, prescription drug comparison and enrollment tools for health plans, pharmacy benefit managers, pharmacies, field marketing organizations and call centers. The Private Exchange segment offers defined-contribution benefit exchange solutions to benefit consultants, brokers, exchange operators and aggregators.Read More Ad The Freeport SocietyThe last Republican president?History shows Donald Trump is poised to go down as the last Republican President for a generation or more. How is this possible, with Biden so unpopular, and Trump running at least neck-in-neck with him in polls?This presentation explains exactly why. CNXR Stock News HeadlinesApril 17, 2024 | nasdaq.comFirst Week of May 31st Options Trading For JD.com (JD)June 22, 2023 | msn.comBig Daddy Kane, Fat Joe, GloRilla & More To Honor Hip Hop 50 At BET AwardsJune 20, 2023 | msn.comWould Gonzaga's Drew Timme be a good fit for the Lakers?June 20, 2023 | msn.comMan found guilty of killing ex-girlfriend at Worcester RestaurantJune 20, 2023 | msn.com10 essentials every gardener should have in their tool kitJune 20, 2023 | msn.com3 Dead After Crash on I-80 in Centre CountyJune 10, 2023 | msn.comCivic calendar | Trinidad will consider creating an emergency response teamApril 8, 2023 | msn.comAugusta National’s Par 3 contest is a delightful family affair ahead of the MastersMarch 4, 2023 | msn.comUmesh Pal's killers lay low in Prayagraj for 2 hours after attack, had 2 getaway vehicles: SourcesOctober 20, 2022 | msn.com‘Holy Fvck’ Tour: Demi Lovato’s Triumphant Punk Era Is Their Best YetSeptember 15, 2022 | nasdaq.comFLCB Enters Oversold TerritoryAugust 2, 2022 | msn.comUncoupled’s Tisha Campbell And Marcia Gay Harden On Learning From Each Other While Working On The Netflix SeriesJune 2, 2022 | nasdaq.comAdd Up The Parts: VIG Could Be Worth $181October 23, 2021 | msn.comPhotos of triplet sisters marrying triplet brothers break the internetSee More Headlines Receive CNXR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (CNXR) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2016Today6/13/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorComputer and Technology Industry Prepackaged Software Sub-IndustryN/A Current SymbolOTCMKTS:CNXR Previous SymbolNASDAQ:CNXR CUSIPN/A CIK1211759 Webwww.connecture.com Phone262-432-8282FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesDavid A. Jones Jr. (Age 67)Independent Chairman of the Board Jeffery Surges (Age 49)President, Chief Executive Officer, Director Brian Lindstrom (Age 46)Chief Financial Officer, Corporate Secretary Vincent E. Estrada (Age 52)Executive Vice President - Corporate Development David A. Sockel (Age 53)Executive Vice President - Strategy and Corporate Development Lea DeVillers (Age 48)General Counsel Mark E. Granville (Age 61)Chief Delivery Officer Kraig McEwenDirectorEzra Perlman (Age 45)Director A. John Ansay (Age 60)Independent Director More ExecutivesKey CompetitorsAdstarOTCMKTS:ADSTArtificial LifeOTCMKTS:ALIFCelerity SolutionsOTCMKTS:CLTYClarentOTCMKTS:CLRNCloopen GroupNYSE:RAASView All Competitors CNXR Stock Analysis - Frequently Asked Questions How were (CNXR)'s earnings last quarter? (CNXR) (OTCMKTS:CNXR) issued its earnings results on Monday, August, 8th. The technology company reported ($0.47) earnings per share for the quarter, missing analysts' consensus estimates of ($0.22) by $0.25. The technology company earned $18.70 million during the quarter, compared to the consensus estimate of $18.21 million. The company's revenue for the quarter was down 19.9% compared to the same quarter last year. What other stocks do shareholders of (CNXR) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (CNXR) investors own include Biocept (BIOC), Novavax (NVAX), Rite Aid (RAD), Athersys (ATHX), Palatin Technologies (PTN), Acer Therapeutics (ACER), Alimera Sciences (ALIM), Allena Pharmaceuticals (ALNA) and This page (OTCMKTS:CNXR) was last updated on 6/13/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredLike Investing in Big Tech in the Early 2000s?More than a decade after the first Bitcoin was mined, people are finally realizing something very important......Manward Press | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more poten...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (CNXR) Please log in to your account or sign up in order to add this asset to your watchlist. Share (CNXR) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.